Keensight Capital Acquires Majority Stake in Axxam
July 28, 2022
Keensight Capital has agreed to acquire a majority stake in Axxam, an Italian innovative partner research organization (iPRO) headquartered in Milan, investing alongside Axxam's management. The sellers include current shareholders such as Bayer SpA and Zambon Company SpA; Axxam employs around 180 people and reported roughly €30 million of sales in 2021. Keensight intends to support the management team to accelerate growth and further develop Axxam's discovery capabilities.
- Buyers
- Keensight Capital, Axxam management
- Targets
- Axxam
- Sellers
- Bayer SpA, Zambon Company SpA
- Industry
- Biotechnology
- Location
- Lombardy, Italy
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.